• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高活性纳米反应器响应肿瘤微环境及抗肿瘤治疗

Highly Active Nano-Reactor for Responding Tumor Microenvironment and Antitumor Therapy.

机构信息

66571Tianjin First Central Hospital, Tianjin, China.

Renji Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221095670. doi: 10.1177/15330338221095670.

DOI:10.1177/15330338221095670
PMID:35712964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9210091/
Abstract

The tumor microenvironment is complex and changeable, so the design of a nano-delivery system for the tumor microenvironment has attracted wide attention. Based on this, we designed an intelligent nano-reactor for the characteristics of acidic pH and hypoxia in the tumor microenvironment. Firstly, the silver nano-balls were synthesized by the biological template method, which exhibited a good photothermal conversion efficiency and can realize the photothermal treatment of tumor sites. Subsequently, the hypoxic prodrug tirapazamine (TPZ) and polydopamine (PDA) for chemotherapy were self-assembled. After PDA arrived at the tumor site (pH 5.5) from the normal physiological environment (pH 7.4), the hypoxic prodrug TPZ was released in pH response by PDA. Subsequently, TPZ selectively induced obvious cell damage under tumor hypoxia stimulation but had no toxic effect on normal cells under normal oxygen. In addition, the nano-converter was loaded with iRGD on the surface, which enhanced the targeted delivery of the nano-reactor to achieve a highly effective antitumor effect. The nano-reactor was capable of combining photothermal/chemotherapy therapy. Importantly, it can selectively kill tumor cells without damaging normal cells based on the characteristics of the tumor microenvironment, with high bio-safety and clinical transformation potential.

摘要

肿瘤微环境复杂多变,因此针对肿瘤微环境的纳米递药系统设计受到了广泛关注。基于此,我们针对肿瘤微环境酸性 pH 值和缺氧的特点设计了一种智能纳米反应器。首先,通过生物模板法合成了银纳米球,其表现出良好的光热转换效率,能够实现肿瘤部位的光热治疗。随后,将缺氧前药替拉扎明(TPZ)和用于化疗的聚多巴胺(PDA)自组装。当 PDA 从正常生理环境(pH7.4)到达肿瘤部位(pH5.5)时,PDA 通过 pH 响应释放缺氧前药 TPZ。随后,TPZ 在肿瘤缺氧刺激下选择性地诱导明显的细胞损伤,但在正常氧下对正常细胞没有毒性作用。此外,纳米转化器表面负载 iRGD,增强了纳米反应器的靶向递送,实现了高效的抗肿瘤效果。该纳米反应器能够结合光热/化疗治疗。重要的是,它可以根据肿瘤微环境的特点选择性地杀死肿瘤细胞而不损伤正常细胞,具有较高的生物安全性和临床转化潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/a6080d8a68d8/10.1177_15330338221095670-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/b0b13cc1db7e/10.1177_15330338221095670-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/5a5f5228686d/10.1177_15330338221095670-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/8d975f535a2f/10.1177_15330338221095670-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/4abf8be92e58/10.1177_15330338221095670-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/d7ff6b9ea77a/10.1177_15330338221095670-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/1bb9bbee6c90/10.1177_15330338221095670-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/a6080d8a68d8/10.1177_15330338221095670-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/b0b13cc1db7e/10.1177_15330338221095670-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/5a5f5228686d/10.1177_15330338221095670-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/8d975f535a2f/10.1177_15330338221095670-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/4abf8be92e58/10.1177_15330338221095670-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/d7ff6b9ea77a/10.1177_15330338221095670-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/1bb9bbee6c90/10.1177_15330338221095670-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd0/9210091/a6080d8a68d8/10.1177_15330338221095670-fig6.jpg

相似文献

1
Highly Active Nano-Reactor for Responding Tumor Microenvironment and Antitumor Therapy.高活性纳米反应器响应肿瘤微环境及抗肿瘤治疗
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221095670. doi: 10.1177/15330338221095670.
2
Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.基于 ICG/PDA/TPZ 载药纳米粒子的联合癌症化疗-光动力和光热治疗。
Mol Pharm. 2019 May 6;16(5):2172-2183. doi: 10.1021/acs.molpharmaceut.9b00119. Epub 2019 Apr 12.
3
Tumor microenvironment-responsive S-NSs-TPZ-ICG intelligent nanoplatforms for synergistically enhanced tumor multimodal therapy.肿瘤微环境响应型 S-NSs-TPZ-ICG 智能纳米平台用于协同增强肿瘤多模式治疗。
Chem Commun (Camb). 2022 May 24;58(42):6251-6254. doi: 10.1039/d2cc01165d.
4
Precise gliomas therapy: Hypoxia-activated prodrugs sensitized by nano-photosensitizers.精准脑胶质瘤治疗:缺氧激活前药经纳米光敏剂增敏。
Biomaterials. 2022 Oct;289:121770. doi: 10.1016/j.biomaterials.2022.121770. Epub 2022 Sep 1.
5
Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.载全氟正丁基三胺/替拉扎明的聚多巴胺包覆的 UiO-66 纳米粒子用于缺氧激活骨肉瘤治疗。
J Nanobiotechnology. 2021 Sep 30;19(1):298. doi: 10.1186/s12951-021-01013-0.
6
Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.载缺氧激活前药的多功能治疗性脂质体用于级联激活的肿瘤选择性联合治疗。
ACS Appl Mater Interfaces. 2019 Oct 30;11(43):39410-39423. doi: 10.1021/acsami.9b11080. Epub 2019 Oct 16.
7
HS-driven chemotherapy and mild photothermal therapy induced mitochondrial reprogramming to promote cuproptosis.热休克蛋白驱动的化疗和温和光热疗法诱导线粒体重编程以促进铜死亡。
J Nanobiotechnology. 2024 Apr 24;22(1):205. doi: 10.1186/s12951-024-02480-x.
8
Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and HO-dependent chemodynamic therapy.具有葡萄糖耗竭作用的自催化癌基因治疗纳米系统,用于级联放大缺氧激活化疗和 HO 依赖性化学动力学治疗。
Biomater Sci. 2022 May 4;10(9):2358-2369. doi: 10.1039/d1bm01944a.
9
Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors.通过 Combretastatin A4 纳米药物选择性增强缺氧水平:实现高度增强的缺氧激活前药替拉扎胺治疗转移性肿瘤。
Adv Mater. 2019 Mar;31(11):e1805955. doi: 10.1002/adma.201805955. Epub 2019 Jan 24.
10
Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor.用于协同光动力化疗治疗缺氧肿瘤的工程仿生纳米反应器。
J Control Release. 2022 Nov;351:151-163. doi: 10.1016/j.jconrel.2022.09.020. Epub 2022 Sep 22.

本文引用的文献

1
Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.载 LDLR 抗体的 TPZ@Ce6-PEG 复合物用于肿瘤乏氧靶向的化疗/放疗/光动力/光热治疗。
J Mater Chem B. 2020 Jan 28;8(4):648-654. doi: 10.1039/c9tb02248a. Epub 2020 Jan 3.
2
Nano-drug System Based on Hierarchical Drug Release for Deep Localized/Systematic Cascade Tumor Therapy Stimulating Antitumor Immune Responses.基于分级药物释放的纳米药物系统用于深部局部/系统性级联肿瘤治疗以刺激抗肿瘤免疫反应。
Theranostics. 2019 May 4;9(10):2897-2909. doi: 10.7150/thno.33534. eCollection 2019.
3
Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation.
磁性靶向、肿瘤微环境响应智能纳米催化剂增强肿瘤消融。
ACS Nano. 2018 Nov 27;12(11):11000-11012. doi: 10.1021/acsnano.8b05042. Epub 2018 Oct 25.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Responsive Assembly of Upconversion Nanoparticles for pH-Activated and Near-Infrared-Triggered Photodynamic Therapy of Deep Tumors.上转换纳米粒子的响应组装用于 pH 激活和近红外触发的深部肿瘤光动力治疗。
Adv Mater. 2018 Aug;30(35):e1802808. doi: 10.1002/adma.201802808. Epub 2018 Jul 12.
6
Improving immune-vascular crosstalk for cancer immunotherapy.改善免疫-血管串扰以用于癌症免疫治疗。
Nat Rev Immunol. 2018 Mar;18(3):195-203. doi: 10.1038/nri.2017.145. Epub 2018 Jan 15.
7
Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.通过利用肿瘤微环境增强抗癌治疗的纳米颗粒设计策略。
Chem Soc Rev. 2017 Jun 21;46(12):3830-3852. doi: 10.1039/c6cs00592f. Epub 2017 May 18.
8
Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.替拉扎胺(TPZ)通过缺氧靶向作用诱导 Chk1/2 激活,从而优先抑制鼻咽癌细胞生长。
Invest New Drugs. 2011 Jun;29(3):401-10. doi: 10.1007/s10637-009-9356-z. Epub 2009 Dec 16.